Thomas Weaver
Fondateur chez PetMedix Ltd.
Profil
Thomas A.
Weaver is the founder and CEO of PetMedix Ltd.
since 2018.
He is also the founder of Congenica Ltd.
Currently, he is a Non-Executive Director at Maxion Therapeutics Ltd.
since 2022.
Previously, he was a Director at Source BioScience Ltd.
from 2007 to 2008 and Vice President-Sales at MPC Corp.
Dr. Weaver received his undergraduate and doctorate degrees from the University of Wisconsin.
Postes actifs de Thomas Weaver
| Sociétés | Poste | Début |
|---|---|---|
PetMedix Ltd.
 PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Fondateur | 01/01/2018 |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Directeur/Membre du Conseil | 01/03/2022 |
Anciens postes connus de Thomas Weaver
| Sociétés | Poste | Fin |
|---|---|---|
| SOURCE BIOSCIENCE PLC | Directeur/Membre du Conseil | 31/07/2008 |
Congenica Ltd.
 Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Fondateur | - |
MPC Corp.
 MPC Corp. Packaged SoftwareTechnology Services MPC Corp. is engaged in development, manufacturing and marketing of network acceleration and data compression software. The company was founded in 2001 and is headquartered in Nampa, ID. | Sales & Marketing | - |
Formation de Thomas Weaver
| University of Wisconsin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Source BioScience Ltd.
 Source BioScience Ltd. Medical/Nursing ServicesHealth Services Source BioScience Ltd. engages in providing integrated state-of-the-art laboratory services. It focuses on supporting clients in the healthcare industry, pharmaceutical sector, and life science academia. The company was founded on November 14, 1903 and is headquartered in Nottingham, the United Kingdom. | Health Services |
MPC Corp.
MPC Corp. Packaged SoftwareTechnology Services MPC Corp. is engaged in development, manufacturing and marketing of network acceleration and data compression software. The company was founded in 2001 and is headquartered in Nampa, ID. | Technology Services |
Congenica Ltd.
Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Health Technology |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Health Technology |
